Acute Reduction News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Acute Reduction. Real-time updates on events, politics, business and more.

Milestone Pharmaceuticals Announces Etripamil AFib-RVR Study is Selected for Featured Science Presentation at the American Heart Association Scientific Sessions 2023

September 27, 2023

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that results from a double-blind, randomized, placebo-controlled Phase 2...

United Kingdom United States City Of David Bharucha Kim Fox Milestone Pharmaceuticals Inc

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Acute Reduction News Today

Milestone Pharmaceuticals Announces Etripamil AFib-RVR Study is Selected for Featured Science Presentation at the American Heart Association Scientific Sessions 2023

Explore More Categories